ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
138.15
-0.25
(-0.18%)
Closed December 21 4:00PM
Realtime Data

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
138.15
Bid
137.35
Ask
138.90
Volume
9,532
136.15 Day's Range 139.10
136.15 52 Week Range 176.90
Market Cap
Previous Close
138.40
Open
137.60
Last Trade
2
@
137.75
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
9,015
Shares Outstanding
129,242,251
Dividend Yield
1.59%
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
20.99B
Net Profit
2.82B

About Merck KGAA

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Diversified
Website
Headquarters
Darmstadt, Deu
Founded
1987
Merck KGAA is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker MRK. The last closing price for Merck KGAA was 138.40 €. Over the last year, Merck KGAA shares have traded in a share price range of 136.15 € to 176.90 €.

Merck KGAA currently has 129,242,251 shares outstanding. The market capitalization of Merck KGAA is 17.89 € billion.

MRK Latest News

Imugene Announces Clinical Trial Supply Agreement with Merck KGaA, Darmstadt, Germany and Pfizer to Evaluate HER-Vaxx in Combination with Avelumab for Treatment of Gastric Cancer

New clinical trial supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer Inc.Avelumab (BAVENCIO®) to be provided to Imugene for Phase 2 clinical study in HER-2 positive gastric or...

Putting the Patient First: Merck Serono to Present Data That Embodies the ESMO 2014 Theme of 'Precision Medicine in Cancer Ca...

Putting the Patient First: Merck Serono to Present Data That Embodies the ESMO 2014 Theme of 'Precision Medicine in Cancer Care' PR Newswire DARMSTADT, Germany, September 26, 2014 DARMSTADT...

Merck Serono Awards Grant for Growth Innovation (GGI) for the First Time

Merck Serono Awards Grant for Growth Innovation (GGI) for the First Time PR Newswire DARMSTADT, Germany, September 19, 2014 DARMSTADT, Germany, September 19, 2014 /PRNewswire/ -- The first grants...

Merck Announces Detailed 26-Week Results from Phase IIIb Study with Kuvan in Children with PKU Below 4 Years of Age

Merck Announces Detailed 26-Week Results from Phase IIIb Study with Kuvan in Children with PKU Below 4 Years of Age PR Newswire DARMSTADT, Germany, September 3, 2014 DARMSTADT, Germany, September...

Merck Serono Announces Groundbreaking of New Pharmaceutical Manufacturing Facility in China, its Second Largest Worldwide

Merck Serono Announces Groundbreaking of New Pharmaceutical Manufacturing Facility in China, its Second Largest Worldwide PR Newswire NANTONG, China, August 27, 2014 NANTONG, China, August 27...

Merck Serono Announces FDA Clearance for Auxogyn's Early Embryo Viability Assessment (Eeva®) System

Merck Serono Announces FDA Clearance for Auxogyn's Early Embryo Viability Assessment (Eeva®) System PR Newswire DARMSTADT, Germany, June 10, 2014 DARMSTADT, Germany, June 10, 2014 /PRNewswire/...

EMD Serono to Release New Pipeline Data at ASCO 2014 from Early-Stage Investigational Compounds in Difficult-to-Treat Cancers

EMD Serono to Release New Pipeline Data at ASCO 2014 from Early-Stage Investigational Compounds in Difficult-to-Treat Cancers PR Newswire ROCKLAND, Massachusetts, May 29, 2014 ROCKLAND...

Merck Serono's President & CEO Belén Garijo has Been Appointed to Board of Directors of L'Oréal

Merck Serono's President & CEO Belén Garijo has Been Appointed to Board of Directors of L'Oréal PR Newswire DARMSTADT, Germany and PARIS, April 17, 2014 DARMSTADT, Germany and PARIS, April...

European Commission Approves Update of Erbitux Metastatic Colorectal Cancer Labeling to Patients With RAS Wild-Type Tumors

European Commission Approves Update of Erbitux Metastatic Colorectal Cancer Labeling to Patients With RAS Wild-Type Tumors PR Newswire DARMSTADT, Germany, December 23, 2013 DARMSTADT, Germany...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-5.29999-3.69466041789143.44999143.44999136.159192139.22478481DE
4-1.29999-0.932226671368139.44999146.19999136.159437141.46889733DE
12-22.79999-14.165884695160.94999168.1136.159015148.74178608DE
26-26.65-16.1711165049164.8176.9136.157759154.52105034DE
52-4.1-2.88224956063142.25176.9136.158315154.49875727DE
156-79.55-36.5411116215217.7231.5134.35181500173.88429839DE
26034.132.7727054301104.05231.576.22291956148.0447112DE

MRK - Frequently Asked Questions (FAQ)

What is the current Merck KGAA share price?
The current share price of Merck KGAA is 138.15 €
How many Merck KGAA shares are in issue?
Merck KGAA has 129,242,251 shares in issue
What is the market cap of Merck KGAA?
The market capitalisation of Merck KGAA is EUR 17.89B
What is the 1 year trading range for Merck KGAA share price?
Merck KGAA has traded in the range of 136.15 € to 176.90 € during the past year
What is the reporting currency for Merck KGAA?
Merck KGAA reports financial results in EUR
What is the latest annual turnover for Merck KGAA?
The latest annual turnover of Merck KGAA is EUR 20.99B
What is the latest annual profit for Merck KGAA?
The latest annual profit of Merck KGAA is EUR 2.82B
What is the registered address of Merck KGAA?
The registered address for Merck KGAA is FRANKFURTER STRASSE 250, DARMSTADT, 64293
What is the Merck KGAA website address?
The website address for Merck KGAA is www.merck.de
Which industry sector does Merck KGAA operate in?
Merck KGAA operates in the PHARMACEUTICAL DIVERSIFIED sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
GX6TPI Composites Inc
2.258 €
(92.66%)
18.75k
LTIAptose Biosciences Inc
0.278 €
(68.48%)
430.65k
36GGBM Resources Limited
0.008 €
(60.00%)
102.8k
7ZGAskari Metals Ltd
0.0104 €
(48.57%)
155k
VOPInvestigator Resources Ltd
0.017 €
(47.83%)
23.1k
PHPNGalectin Therapeutics Inc
0.90 €
(-53.61%)
3.69k
AWY0Percheron Therapeutics Ltd
0.0025 €
(-44.44%)
658.15k
H5EHelma Eigenheimbau Ag
0.04 €
(-40.83%)
29.35k
7KOCullinan Metals Corp
0.0076 €
(-35.59%)
3.5k
W47Grid Battery Metals Inc
0.01 €
(-35.48%)
1,000
AXIAtos SE
0.0021 €
(0.00%)
474.93M
D7GNel ASA
0.253 €
(-0.16%)
4.33M
RQ0DWave Quantum Inc
6.38 €
(3.44%)
2.96M
R9BDeFi Technologies Inc
2.67 €
(10.56%)
2.3M
3CPXiaomi Corporation
3.886 €
(2.47%)
2.29M

Discussion

View Full Feed
Monksdream Monksdream 4 minutes ago
OTLK, under $2
https://investorshub.advfn.com/uimage/uploads/2024/12/21/[lrcrIMG_4054.gif
OTLK
Flobewan Flobewan 5 minutes ago
63 here for the next couple of days, then 50s, no single digits in site for a while
Myth Myth 5 minutes ago
sure are, now it seems everyone's getting them for XMAS....lol.....
Zadie420 Zadie420 6 minutes ago
dstock, thanks for your great DDs. I am referencing to your statement here: "UCLA did have four or five years of research on the combination of DCVax-L + Opdivo + PLX3397."
The problem is all these type of early trials was performed by third party, like UCLA, Merck,..... So they can take the
NWBO
jobynimble jobynimble 6 minutes ago
Done…

Your symbol request has been submitted. If you'd like to submit another symbol, please click here.
Myth Myth 6 minutes ago
Elvis Presley - Way Down

https://www.youtube.com/watch?v=weLSA2vekLA
Monksdream Monksdream 6 minutes ago
HLVX, under $2
https://investorshub.advfn.com/uimage/uploads/2024/12/21/r[hbbIMG_4053.gif
HLVX
pos_stock_hoarder pos_stock_hoarder 7 minutes ago
Those commercials are so over-the-top!
eyeownu eyeownu 7 minutes ago
LOADING ZONE
PW
eyeownu eyeownu 7 minutes ago
LOADING ZONE
PW
ignatiusrielly35 ignatiusrielly35 7 minutes ago
I'm not sure how we can have a "big dip" below .03 but good luck. I will just hold my shares because there is no point in selling at this price. However, I'm guessing this company is most likely done.
NEXCF
cjstocksup cjstocksup 7 minutes ago
Biden went back to sign the bill.
Something is happening . . . Biden Abruptly Stops Delaware Christmas Vacation - Returns to White House ; Harris CANCELS Scheduled trip to California, Returns to White House
alertmeipp alertmeipp 8 minutes ago
Potentially a lot higher. But probably will take some times -

1) favorable term on settlement - any time.
2) partnerships - any time, but likely 6 months
3) buyout - any time.
4) successful HR result - 6 months

EV dropped from 1.5 billions all the
ENTA
looking 4 a win looking 4 a win 8 minutes ago
The bigger the correction the bigger the bounce. 
DOGEUSD
dexprs dexprs 9 minutes ago
My ad blocking works very well, try it.
PickStocks PickStocks 9 minutes ago
Creative accounting is what the 14 billion entry is....
COOP
Monksdream Monksdream 10 minutes ago
IPSC, under $2
https://investorshub.advfn.com/uimage/uploads/2024/12/21/ukslfIMG_4052.gif
IPSC
Gmenfan Gmenfan 10 minutes ago
The rage of George Stephanopoulos

By Monica Showalter


What a wretched character. If ABC sticks with this guy, they will deserve him.



ABC News host George Stephanopoulos, who forced his network to cough up $15 million to Donald Trum
Gmenfan Gmenfan 10 minutes ago
The rage of George Stephanopoulos

By Monica Showalter


What a wretched character. If ABC sticks with this guy, they will deserve him.



ABC News host George Stephanopoulos, who forced his network to cough up $15 million to Donald Trum
Konaploinks Konaploinks 10 minutes ago
Jack. I think U K is coming around as he reads more and is more educated on Ionq and quantum computing . Time will tell if he’s attempting to be a “soft bashturd ” We shall see
IONQ
pos_stock_hoarder pos_stock_hoarder 10 minutes ago
You get to sing "it's the most wonderful time of the year". Loudly! Enjoy.
cjstocksup cjstocksup 11 minutes ago
They were right! They did not want to raise the debt ceiling after promising we would not. Trump is not happy either but with Shumer in charge it was the only way to get it done. Now Biden has 100 billion dollars he can spend in the next month. It is not good when they are supposed to be reducing th
pos_stock_hoarder pos_stock_hoarder 11 minutes ago
3 pillars of Islam

https://stebilex.com/wp-content/uploads/Bollard-Maintenance-by-Stebilex-Systems-in-UAE.jpg
DrJan DrJan 11 minutes ago
This is a centralized procedure. Representatives of each country will vote and based on the majority it's yes or no approved for marketing for all countries. If marketing authorisation is achieved then reimbursement criteria are a decision for each country separately.
AVXL

Your Recent History

Delayed Upgrade Clock